Clinical trial
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
NCT00006305 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00006305 |
|---|---|
| Title | Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes |
| Official title | Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes |
| Acronym | BARI2D |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Disease, Cardiovascular Diseases, Heart Diseases, Insulin Resistance, Diabetes Mellitus, Non-Insulin-Dependent |
| Intervention type | Drug, Procedure |
| Interventions | Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions, Coronary Artery Bypass, Biguanides, thiazolidinediones, Insulin, sulfonylurea, ACE Inhibitors and 3 more |
| Enrollment | 2,368 |
| Start date | Sep 1, 2000 |
| Primary completion | Nov 1, 2008 |
| Completion | Mar 1, 2009 |
| First posted | Sep 29, 2000 |
| Last update posted | Feb 8, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: